Last reviewed · How we verify
NCT04431583
Transition of Single Surgeon Bariatric Service to an Interdisciplinary Multiple Surgeon Model
trial testing Bariatric surgery- single surgeon service in Obesity in 146 participants. Completed in 3 June 2020.
31 December 2018
Quick facts
| Lead sponsor | University of Adelaide |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 146 |
| Start date | 1 January 2008 |
| Primary completion | 31 December 2018 |
| Estimated completion | 3 June 2020 |
Drugs / interventions tested
- Bariatric surgery- single surgeon service
- Bariatric surgery- multiple surgeon + multidisciplinary team approach
- Bariatric surgery: formalized streamlined multiple surgeon + multidisciplinary team approach
Conditions studied
- Obesity — all drugs for Obesity →
- Bariatric Surgery Candidate — all drugs for Bariatric Surgery Candidate →
Sponsor
University of Adelaide
Who can join
Eligibility, any sex, with Obesity or Bariatric Surgery Candidate. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This retrospective study will analyse the transition of an Australian hospital which significantly increased volume of bariatric operations after introduction of a clinical pathway, and to assess the outcomes. Barriers to introduction of the multidisciplinary pathway and the means to overcome these will also be analysed and discussed. The analysis will also determine if there are any other areas of bariatric surgery which can be further investigated to optimise current practice.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04431583
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Obesity
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
- NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting
Other University of Adelaide trials
Trials by the same sponsor.
- NCT07013656 — Effects of Combined Administration of Calcium and L-tryptophan on Gut Functions and Blood Glucose in Healthy Humans · NA · not yet recruiting
- NCT06890507 — The Anti-Anginal Effects of N-Acetylcysteine (NAC) in Patients with Angina and Non-Obstructive Coronary Arteries (ANOCA) · Phase 2 · not yet recruiting
- NCT06942195 — Effects of Calcium on Gut Functions and Blood Glucose in Humans With Type 2 Diabetes · NA · recruiting
- NCT05682339 — Effects of Intragastric Quinine, Alone or Combined With L-isoleucine, on Postprandial Glycaemic Control · NA · completed
- NCT05769335 — Calories or Time Restriction to Alter Biomarkers of Aging and Diabetes · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04431583 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Adelaide
- Last refreshed: 16 June 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04431583.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing